Literature DB >> 18506777

Regulation of insulin receptor substrate-1 expression levels by caveolin-1.

Jia Chen1, Franco Capozza, An Wu, Tiziana Deangelis, Hongzhi Sun, Michael Lisanti, Renato Baserga.   

Abstract

The insulin receptor substrate-1 (IRS-1), a docking protein of the type 1 insulin-like growth factor receptor (IGF-IR) plays a significant role in cell proliferation and differentiation. The expression of IRS-1 is down-regulated in mouse embryo fibroblasts (MEFs) with a deletion of caveolin-1 (cav1) genes (KO cells). Levels of IRS-1 mRNA are not affected. Re-introduction of cav1 into KO cells rescues IRS-1 expression. Stabilization of protein levels is reciprocal and a strict correlation between IRS-1 and cav1 levels was confirmed in five cell lines, and in mouse tissues. IRS-1 binds through its phosphotyrosine binding (PTB) domain to tyrosine 14 (Y14) of cav1, the residue phosphorylated by IGF-1 stimulation and by v-src. The down-regulation of IRS-1 in cav-/- cells occurs via the proteasome pathway. These results indicate a novel mechanism for the regulation of IRS-1 expression levels, an important finding in view of IRS-1 role in cell proliferation and transformation. (c) 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18506777     DOI: 10.1002/jcp.21498

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  12 in total

1.  Integrin alpha1beta1 regulates epidermal growth factor receptor activation by controlling peroxisome proliferator-activated receptor gamma-dependent caveolin-1 expression.

Authors:  Xiwu Chen; Carrie Whiting; Corina Borza; Wen Hu; Stacey Mont; Nada Bulus; Ming-Zhi Zhang; Raymond C Harris; Roy Zent; Ambra Pozzi
Journal:  Mol Cell Biol       Date:  2010-04-05       Impact factor: 4.272

Review 2.  Caveolins as Regulators of Stress Adaptation.

Authors:  Jan M Schilling; Brian P Head; Hemal H Patel
Journal:  Mol Pharmacol       Date:  2018-01-22       Impact factor: 4.436

3.  17β-Estradiol attenuates diet-induced insulin resistance and glucose intolerance through up-regulation of caveolin-3.

Authors:  P Mu; Z Tan; Y Cui; H Liu; X Xu; Q Huang; L Zeng; T Wang
Journal:  Ir J Med Sci       Date:  2010-10-17       Impact factor: 1.568

Review 4.  Caveolin-1 and polymerase I and transcript release factor: new players in insulin-like growth factor-I receptor signaling.

Authors:  M Hamoudane; S Maffioli; R Cordera; D Maggi; B Salani
Journal:  J Endocrinol Invest       Date:  2013-02-12       Impact factor: 4.256

5.  Reverse-phase protein array profiling of oropharyngeal cancer and significance of PIK3CA mutations in HPV-associated head and neck cancer.

Authors:  Andrew Sewell; Brandee Brown; Asel Biktasova; Gordon B Mills; Yiling Lu; Darren R Tyson; Natalia Issaeva; Wendell G Yarbrough
Journal:  Clin Cancer Res       Date:  2014-03-05       Impact factor: 12.531

6.  IGF1R signaling in Ewing sarcoma is shaped by clathrin-/caveolin-dependent endocytosis.

Authors:  Ana Sofia Martins; José Luis Ordóñez; Ana Teresa Amaral; Frans Prins; Giuseppe Floris; Maria Debiec-Rychter; Pancras C W Hogendoorn; Enrique de Alava
Journal:  PLoS One       Date:  2011-05-17       Impact factor: 3.240

7.  The role of the Niemann-Pick disease, type C1 protein in adipocyte insulin action.

Authors:  Rachael Fletcher; Christopher Gribben; Xiuquan Ma; Xuiquan Ma; James G Burchfield; Kristen C Thomas; James R Krycer; David E James; Daniel J Fazakerley
Journal:  PLoS One       Date:  2014-04-21       Impact factor: 3.240

Review 8.  Contributions of quantitative proteomics to understanding membrane microdomains.

Authors:  Yu Zi Zheng; Leonard J Foster
Journal:  J Lipid Res       Date:  2009-07-03       Impact factor: 5.922

9.  Activation of Akt by advanced glycation end products (AGEs): involvement of IGF-1 receptor and caveolin-1.

Authors:  Su-Jung Yang; Chen-Yu Chen; Geen-Dong Chang; Hui-Chin Wen; Ching-Yu Chen; Shi-Chuan Chang; Jyh-Fei Liao; Chung-Ho Chang
Journal:  PLoS One       Date:  2013-03-05       Impact factor: 3.240

10.  Increased interaction with insulin receptor substrate 1, a novel abnormality in insulin resistance and type 2 diabetes.

Authors:  Michael Caruso; Danjun Ma; Zaher Msallaty; Monique Lewis; Berhane Seyoum; Wissam Al-janabi; Michael Diamond; Abdul B Abou-Samra; Kurt Højlund; Rebecca Tagett; Sorin Draghici; Xiangmin Zhang; Jeffrey F Horowitz; Zhengping Yi
Journal:  Diabetes       Date:  2014-02-28       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.